To confirm the importance of Bcl-xL in TAN survival, we injected tumor-bearing mice with a single dose of BrdU and started A-1331852 treatment the next morning for a duration of 8 days before sacrifice (see scheme Fig. 3D). The gene discussed is BCL2L1; the disease is neoplasm.